Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
77 0% |
 |
Gilead SciencesGILD |
60 3.4% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Nov 2024 | 56 | |
| Oct 2024 | 51 | |
| Sep 2024 | 50 | |
| Aug 2024 | 49 |
How do employees feel about the future at PTC Therapeutics?
The Business Outlook at PTC Therapeutics is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 56 out of 100 is decent.
Analyzing Business Outlook, how is PTC Therapeutics performing compared to its industry peers?
Compared to its peers, PTC Therapeutics ranks in the 56th percentile when it comes to Business Outlook.
How has the business outlook at PTC Therapeutics changed over the last couple of months
In recent months, PTC Therapeutics' employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at PTC Therapeutics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at PTC Therapeutics.
